Ciani O - Search Results

1

Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence.

Ciani O, Grigore B, Taylor RS. Ciani O, et al. Health Econ. 2022 Sep;31 Suppl 1(Suppl 1):44-72. doi: 10.1002/hec.4524. Epub 2022 May 24. Health Econ. 2022. PMID: 35608044 Free PMC article.

2

A more evidence based approach to the use of surrogate end points in policy making.

Ciani O, Taylor RS. Ciani O, et al. BMJ. 2011 Oct 25;343:d6498. doi: 10.1136/bmj.d6498. BMJ. 2011. PMID: 22027353 No abstract available.

3

Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses.

Ciani O, Taylor RS. Ciani O, et al. Health Econ. 2013 Feb;22(2):251-2. doi: 10.1002/hec.2826. Epub 2012 May 24. Health Econ. 2013. PMID: 22623328

4

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.

Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, Taylor RS. Ciani O, et al. BMJ. 2013 Jan 29;346:f457. doi: 10.1136/bmj.f457. BMJ. 2013. PMID: 23360719 Free PMC article. Review.

5

Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis.

Taylor RS, Piepoli MF, Smart N, Coats AJ, Ellis S, Dalal H, O'Connor CM, Warren FC, Whellan D, Ciani O; ExTraMATCH II Collaborators. Taylor RS, et al. Among authors: ciani o, o connor cm. Int J Cardiol. 2014 Jul 1;174(3):683-7. doi: 10.1016/j.ijcard.2014.04.203. Epub 2014 Apr 26. Int J Cardiol. 2014. PMID: 24804902

6

Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.

Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad ED, Buyse M, Taylor RS. Ciani O, et al. Int J Technol Assess Health Care. 2014 Jul;30(3):312-24. doi: 10.1017/S0266462314000300. Int J Technol Assess Health Care. 2014. PMID: 25308694 Free article. Review.

7

The role of health technology assessment bodies in shaping drug development.

Ciani O, Jommi C. Ciani O, et al. Drug Des Devel Ther. 2014 Nov 10;8:2273-81. doi: 10.2147/DDDT.S49935. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25419117 Free PMC article.

8

Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer.

Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS. Ciani O, et al. J Clin Epidemiol. 2015 Jul;68(7):833-42. doi: 10.1016/j.jclinepi.2015.02.016. Epub 2015 Mar 6. J Clin Epidemiol. 2015. PMID: 25863582 Free article. Review.

9

Health technology assessment of medical devices: a survey of non-European union agencies.

Ciani O, Wilcher B, Blankart CR, Hatz M, Rupel VP, Erker RS, Varabyova Y, Taylor RS. Ciani O, et al. Int J Technol Assess Health Care. 2015 Jan;31(3):154-65. doi: 10.1017/S0266462315000185. Epub 2015 Jun 5. Int J Technol Assess Health Care. 2015. PMID: 26044729 Free PMC article.

10

Validation of surrogate end points for overall survival in advanced colorectal cancer: A harmonized approach is needed.

Ciani O, Taylor RS. Ciani O, et al. J Clin Epidemiol. 2016 Feb;70:277-8. doi: 10.1016/j.jclinepi.2015.08.020. Epub 2015 Sep 5. J Clin Epidemiol. 2016. PMID: 26348801 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters